{"title":"Effectiveness of Topical Agents in Management of Pain Associated with Myofascial Pain Dysfunction Syndrome-A Systematic Review.","authors":"Harshini Manoharan, Veena K M, Prashanth Shenoy","doi":"10.1080/15360288.2025.2480236","DOIUrl":null,"url":null,"abstract":"<p><p>Various invasive and non-invasive treatment modalities have been performed for the treatment of Myofascial pain dysfunction syndrome (MPDS). Topical agents may be effective with minimal disadvantages, and can be the first line of non-invasive treatment option in the management of MPDS. This systematic review was done to evaluate the safety and effectiveness of topical agents and patches in the management of pain associated with MPDS as a non-invasive management option. According to PRISMA guidelines, the PubMed, Embase, Web of science and Cochrane engine databases were searched for clinical trials which were published till July 2023. A total of 5 articles met the study inclusion criteria. Data were extracted from these studies and a qualitative analysis was performed. Topical agents in forms of ointment, gels and patches was found to improve the pain symptoms along with better quality of life and range of motion in patients with MPDS. This systematic review showed that topical interventions provide a non-invasive option for pain management in MPDS, demonstrating efficacy compared to placebo with a favorable safety profile. However, direct comparisons with invasive methods are limited and further studies directly comparing topical and invasive interventions are needed before establishing them as a first-line treatment.</p>","PeriodicalId":16645,"journal":{"name":"Journal of Pain & Palliative Care Pharmacotherapy","volume":" ","pages":"266-275"},"PeriodicalIF":1.0000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pain & Palliative Care Pharmacotherapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/15360288.2025.2480236","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/9 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ANESTHESIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Various invasive and non-invasive treatment modalities have been performed for the treatment of Myofascial pain dysfunction syndrome (MPDS). Topical agents may be effective with minimal disadvantages, and can be the first line of non-invasive treatment option in the management of MPDS. This systematic review was done to evaluate the safety and effectiveness of topical agents and patches in the management of pain associated with MPDS as a non-invasive management option. According to PRISMA guidelines, the PubMed, Embase, Web of science and Cochrane engine databases were searched for clinical trials which were published till July 2023. A total of 5 articles met the study inclusion criteria. Data were extracted from these studies and a qualitative analysis was performed. Topical agents in forms of ointment, gels and patches was found to improve the pain symptoms along with better quality of life and range of motion in patients with MPDS. This systematic review showed that topical interventions provide a non-invasive option for pain management in MPDS, demonstrating efficacy compared to placebo with a favorable safety profile. However, direct comparisons with invasive methods are limited and further studies directly comparing topical and invasive interventions are needed before establishing them as a first-line treatment.
肌筋膜疼痛功能障碍综合征(MPDS)的治疗采用了多种侵入性和非侵入性治疗方法。局部药物可能是有效的,最小的缺点,可以是一线的非侵入性治疗选择在MPDS的管理。本系统综述是为了评估外用药物和贴片作为一种非侵入性治疗选择在治疗MPDS相关疼痛方面的安全性和有效性。根据PRISMA指南,检索了PubMed, Embase, Web of science和Cochrane引擎数据库,检索了截至2023年7月发表的临床试验。共有5篇文章符合研究纳入标准。从这些研究中提取数据并进行定性分析。发现软膏、凝胶和贴片形式的局部药物可以改善MPDS患者的疼痛症状,改善生活质量和活动范围。本系统综述显示,局部干预为MPDS患者的疼痛管理提供了一种非侵入性的选择,与安慰剂相比,显示出良好的安全性。然而,与侵入性方法的直接比较是有限的,在将其确定为一线治疗方法之前,需要进一步研究直接比较局部干预和侵入性干预。